Wenzhou Medical University signed a technology transfer contract of 10 million yuan with Anke biology

On November 22, Wenzhou Medical University and Anhui Anke Bioengineering (Group) Co., Ltd held a signing ceremony of new drug technology transfer The new generation of thermosensitive gel of fibroblast growth factor (FGF), the second generation of the scientific research team of Wenzhou Medical University, was transferred to Anhui Anke Biological Engineering Group Co., Ltd at a price of 10 million yuan Li Xuekun scientific research team, School of pharmacy, Wenzhou Medical University has developed three national first-class biological products, including recombinant human acidic fibroblast growth factor, recombinant human basic fibroblast growth factor and recombinant bovine basic fibroblast growth factor, which have been widely used in the field of wound repair The research team further deepened the foundation and new drug research and development of FGF from structural biology, signal transmission mechanism, innovative agents, etc.: from paracrine FGF subfamily to new endocrine subfamily; from external agents to internal agents; from traumatic diseases to major diseases such as diabetes, pulmonary fibrosis and neurodegenerative diseases, and made a series of breakthroughs News extension > > On November 22, Anhui xinhuakun Bioengineering Co., Ltd., a subsidiary of Anke biological holding company, signed a technology transfer (patent) contract with Wenzhou Medical University, which stipulated that Wenyi university would transfer the technology "recombinant human acidic fibroblast growth factor diabetic foot treatment technology project" and "biological protein sponge medical material technology" developed by its pharmaceutical college to Xinyi Huakun company, as well as providing technical services for the follow-up product development of recombinant human keratinocyte growth factor-2 for xinhuakun company The contract determines that the total amount of transfer price and technical service fee of technical achievements is 10 million yuan On the afternoon of the same day, the unveiling ceremony of the Undergraduate Practice Base of the school of pharmacy of Wenzhou Medical University was held in Wenzhou Medical University The unveiling ceremony was attended by song Lihua, chairman of the board, Li Xing, director, Wu Rui and other company leaders, Qiu Yi, Secretary of the Party committee of Wenzhou Medical University, and Li Xuekun, vice president and President of the school of pharmacy Academician Liu Changxiao, who is currently the director of the new drug evaluation and research center of Tianjin Pharmaceutical Research Institute and the State Key Laboratory jointly established by the Ministry and the province, the director of the drug metabolism Professional Committee of Chinese Pharmacology Society and the president of Tianjin Pharmacology Society, also attended the unveiling ceremony At the same time, Anke biology has set up the "scholarship of Anke biology" in Wenzhou Medical University.